Discover 601 research papers published on
1st September, 2017 starting with "1"

1295OBlood-based biomarkers for cancer immunotherapy: Tumor mutational burden in blood (bTMB) is associated with improved atezolizumab (atezo) efficacy in 2L+ NSCLC (POPLAR and OAK)

1,3,6-Hexanetricarbonitrile as electrolyte additive for enhancing electrochemical performance of high voltage Li-rich layered oxide cathode

100 kyr fluvial cut-and-fill terrace cycles since the Middle Pleistocene in the southern Central Andes, NW Argentina

12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules.

1140PDPredictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)

1-Year Results of a Randomized Controlled Trial of Conservative Management vs. Minimally Invasive Surgical Treatment for Sacroiliac Joint Pain.

1.4-7.2 μm broadband supercontinuum generation in an As-S chalcogenide tapered fiber pumped in the normal dispersion regime.

18-month outcomes of heterologous bilateral hand transplantation in a child: a case report

100% endemism in mesophotic reef fish assemblages at Kure Atoll, Hawaiian Islands

1141PDCA-170, a first in class oral small molecule dual inhibitor of immune checkpoints PD-L1 and VISTA, demonstrates tumor growth inhibition in pre-clinical models and promotes T cell activation in Phase 1 study

1214OEpacadostat plus pembrolizumab in patients with advanced melanoma: Phase 1 and 2 efficacy and safety results from ECHO-202/KEYNOTE-037

1215OResults of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma

1220PDPhase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

1198PImmunomodulation by regorafenib alone and in combination with anti PD1 antibody on murine models of colorectal cancer

1043OTreatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 study: A biomarker analysis and updated clinical outcomes

1273OResults of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

1216OKEYNOTE-022 update: phase 1 study of first-line pembrolizumab (pembro) plus dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma

168 Gb/s/λ Direct-Detection 64-QAM SSB Nyquist-SCM Transmission over 80 km Uncompensated SSMF at 4.54 b/s/Hz net ISD using a Kramers-Kronig Receiver

11-Mercaptoundecanoic acid functionalized gold nanoclusters as fluorescent probes for the sensitive detection of Cu2+ and Fe3+ ions

15N tracer-based analysis of genotypic differences in the uptake and partitioning of N applied at different growth stages in transplanted rice

1303PDNivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status

18F-FDG PET/CT in preoperative staging of vulvar cancer patients: is it really effective?

138 Tbit/s Transmission over 650 km Graded-Index 6-Mode Fiber

1042ODurvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study

[10]-Gingerol Reverts Malignant Phenotype of Breast Cancer Cells in 3D Culture

10-K Disclosure Repetition and Managerial Reporting Incentives

1299O_PRPrimary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK+ non-small-cell lung cancer (NSCLC)

1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose Binds to the N-terminal Metal Binding Region to Inhibit Amyloid β-protein Oligomer and Fibril Formation.

1306PDHyperprogressive disease (HPD) is frequent in non-small cell lung cancer (NSCLC) patients (pts) treated with anti PD1/PD-L1 monoclonal antibodies (IO)

1977-2017: La investigación enfermera en España tras 40 años en la Universidad

100,000 false positives for every real terrorist: Why anti-terror algorithms don't work

1301PDThree-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)

1314PAssociation between immune-related adverse events (irAEs) and atezolizumab efficacy in advanced NSCLC: analyses from the phase III study OAK

1162PPredictive factors for poor progression-free survival in patients with non-small-cell lung cancer treated with nivolumab

1136ONivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer

1H NMR-based compositional identification of different powdered infant formulas

1044OLong-Term Safety and Clinical Outcomes of Atezolizumab in Head and Neck Cancer: Phase Ia Trial Results

100 Gbaud 4PAM Link for High Speed Optical Interconnects

163PDLong-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto)

1H and 31P benchtop NMR of liquids and solids used in and/or produced during the manufacture of methamphetamine by the HI reduction of pseudoephedrine/ephedrine

11,12 -Epoxyeicosatrienoic acid (11,12 EET) reduces excitability and excitatory transmission in the hippocampus

1298O_PRAlectinib vs crizotinib in treatment-naïve ALK+ NSCLC: CNS efficacy results from the ALEX study

1-Methyl-4-propan-2-ylbenzene from Thymus vulgaris Attenuates Cholinergic Dysfunction

1221PD(Neo-)adjuvant ipilimumab + nivolumab (IPI+NIVO) in palpable stage 3 melanoma – updated relapse free survival (RFS) data from the OpACIN trial and first biomarker analyses

1296OClinical efficacy of atezolizumab (Atezo) in PD-L1 subgroups defined by SP142 and 22C3 IHC assays in 2L+ NSCLC: Results from the randomized OAK study

1143PDDose-finding combination study of niraparib and pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or recurrent platinum-resistant epithelial ovarian cancer (OC) (TOPACIO/Keynote-162)

1135OPhase 1b/2 Study (SCORES) assessing safety, tolerability, and preliminary anti-tumor activity of durvalumab plus AZD9150 or AZD5069 in patients with advanced solid malignancies and squamous cell carcinoma of the head and neck (SCCHN)

1348POverall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies

112 Gb/s PDM-PAM4 Generation and 80 km Transmission Using a Novel Monolithically Integrated Dual-Polarization Electro-Absorption Modulator InP PIC

1383TiPBlood first line ready screening trial (B-F1RST) and blood first assay screening trial (BFAST) enable clinical development of novel blood-based biomarker assays for tumor mutational burden (TMB) and somatic mutations in 1L advanced or metastatic NSCLC

1530PDResults of a randomized, placebo-controlled, phase 2 study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)

1977-2017: Nursing research in Spain after 40 years in the University.

1213OCharacterization of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO or IPI alone

1.032-Tb/s CPRI-Equivalent Data Rate Transmission using IF-over-Fiber System for High Capacity Mobile Fronthaul Links

102PAnalytic validation of a next generation sequencing assay to identify tumor mutational burden from blood (bTMB) to support investigation of an anti-PD-L1 agent, atezolizumab, in a first line non-small cell lung cancer trial (BFAST)

1144OPhase III randomized controlled trial of adjuvant chemoimmunotherapy in patients with resected primary lung cancer

1059PPD-L1 Detection and Assay Performance in Squamous Cell Carcinoma of the Head and Neck Using PD-L1 IHC 28-8 pharmDx

1-Deoxynojirimycin: Sources, Extraction, Analysis and Biological Functions:

1050PDThe ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

13C metabolic flux profiling of Pichia pastoris grown in aerobic batch cultures on glucose revealed high relative anabolic use of TCA cycle and limited incorporation of provided precursors of branched‐chain amino acids

1349PSubsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7

1α,25-Dihydroxyvitamin D 3 enhances TRPV6 transcription through p38 MAPK activation and GADD45 expression

1480PDA phase 2 study of CMB305 and atezolizumab in NY-ESO-1+ soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival

12,000-fps Multi-object detection using HOG descriptor and SVM classifier

13.11: DSM design approach for hot-rolled steel angle columns

16.20: Influence of bearing length on the patch loading resistance of multiple longitudinally stiffened webs

151PDEfficacy and safety of biosimilar ABP 980 compared with trastuzumab in HER2 positive early breast cancer

1331PDetection of EGFR T790M in Asia-Pacific patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Circulating tumour (ct) DNA analysis across 3 platforms

18F-Fluoromisonidazole positron emission tomography (FMISO-PET) may reflect hypoxia and cell proliferation activity in oral squamous cell carcinoma.

1H NMR and MVA metabolomic profiles of urines from piglets fed with boluses contaminated with a mixture of five mycotoxins.

1137OInterim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

1170PAnalysis of POLE mutation and tumor mutational burden (TMB) across 80,853 tumors: Implications for immune checkpoint inhibitors (ICPIs)

1302PDIFCT-1502 CLINIVO: Real-life experience with nivolumab in 600 patients (pts) with advanced non-small cell lung cancer (NSCLC): Efficacy and safety of nivolumab and post-nivolumab treatment in the French Expanded Access Program (EAP)

1473OEncouraging activity of novel pan-KIT and PDGFRα inhibitor DCC-2618 in patients (pts) with Gastrointestinal Stromal Tumor (GIST)

1323PBaseline corticosteroids (CS) could be associated with absence of benefit to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients

1486PAn epidemiological insight into epithelioid sarcoma (ES): The open issue of distal-type (DES) versus proximal-type (PES)

1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads

125 Gbps Pre-Compensated Nonlinear Frequency-Division Multiplexed Transmission

153dB Dynamic Range Calibration-Less Gas Sensor Interface Circuit with Quasi-Digital Output

1244PHospitalization Rates in COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant Melanoma

117PAnti-HER2 therapy efficacy in HER2-negative metastatic breast cancer with HER2-amplified circulating tumor cells: results of the CirCe T-DM1 trial

1187PA Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

1727PDistribution of the PAM50 breast cancer subtypes within each pathology-based group: a combined analysis of 15,339 patients across 29 studies

1344PBrigatinib (BRG) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC): Long-term efficacy and safety results from a phase 1/2 trial

11.01: Shaking table tests on cold‐formed steel building sheathed with gypsum panels

125 μm-cladding 2LP-mode and 4-core Multi-core Fibre with Air-hole Structure for Low Crosstalk in C+L Band

10.15: Thermal modelling of LSF floor systems made of lipped channel and hollow flange channel section joists

1 The association between urban tree cover and gun assault: a case-control and case-crossover study

1346PCNS efficacy results from the phase III ALUR study of alectinib vs chemotherapy in previously treated ALK+ NSCLC

1724PSome mechanisms of increasing malignancy of B16/F10 melanoma in female mice with chronic pain

13 C-Acetic Acid Breath Test Monitoring of Gastric Emptying during Disease Progression in Diabetic Rats

1672PctDNA might expand therapeutic options for second line treatment of KRAS mutant mCRC

1139PDAnalyzing biomarkers of cancer immunotherapy (CIT) response using a real-world clinico-genomic database

1479PDPhase II study of TAS-116, an oral inhibitor of heat shock protein 90 (HSP90), in metastatic or unresectable gastrointestinal stromal tumor refractory to imatinib, sunitinib and regorafenib

10.01: Analytical methods for the prediction of fire resistance of “reinforced” slim floor beams

104 Stereotactic Radiosurgery for Spetzler-Martin Grade IV and V Arteriovenous Malformations: An International Multicenter Study

11.02: In-plane quasi-static cyclic tests on lightweight steel drywall non-structural partition walls

1-D memristor-based cellular automaton for pseudo-random number generation

1040TiPQuANTUM-First: phase 3, double-blind, placebo-controlled study of quizartinib in combination with induction and consolidation chemotherapy, and as maintenance therapy in patients (pts) with newly diagnosed (NDx) FLT3-ITD acute myeloid leukemia (AML)

18% High-Efficiency Air-Processed Perovskite Solar Cells Made in a Humid Atmosphere of 70% RH (Solar RRL 9∕2017)

1256TiPA Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D+T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)

100G to 1T based Coherent PON Technology

1.54 μm photoluminescence from Er:Ox centers at extremely low concentration in silicon at 300 K.

1664PLiprin-α4 could be a potential therapeutic target for pancreatic cancer

1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators

1320PUse of nivolumab in elderly patients with advanced non-squamous NSCLC: Results from the Italian expanded access program (EAP)

1,3-Bis(4-methylbenzyl)imidazol-2-ylidene silver(I) chloride catalyzed carboxylative coupling of terminal alkynes, butyl iodide and carbon dioxide

1- $\mu \text{m}$ Short-Channel Oxide Thin-Film Transistors With Triangular Gate Spacer

1701OComprehensive Genomic Profiling (CGP) of Thymic Gland Carcinomas

1535TiPKEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC)

1/f Noise in 3D vertical gate-all-around junction-less silicon nanowire transistors

1524PAG-120, a novel IDH1 targeted molecule, inhibits invasion and migration of chondrosarcoma cells in vitro

10B(n,α)7Li and 10B(n,α1γ)7Li cross section data up to 3 MeV incident neutron energy

1st metatarso-phalangeal joint arthroplasty with ROTO-glide implant.

1 kHz single-frequency 2.09 μm Ho:YAG ring laser.

1222PDRegional differences in overall survival (OS) in patients with advanced melanoma (MEL) who received nivolumab (NIVO) combined with ipilimumab (IPI) or NIVO alone in a phase 3 trial (CheckMate 067)

155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial

1358PFirst-in-human phase I study of PF-06747775, a third-generation mutant selective EGFR tyrosine kinase inhibitor (TKI) in metastatic EGFR mutant NSCLC after progression on a first-line EGFR TKI

1353PCNS response to osimertinib in Asian-Pacific patients (pts) with T790M-positive advanced NSCLC: data from an open-label Phase II trial (AURA17)

154PDA randomized, double-blind study of PF-05280014 (a potential biosimilar) vs trastuzumab, both given with docetaxel (D) and carboplatin (C), as neoadjuvant treatment for operable human epidermal growth factor receptor 2-positive (HER2+) breast cancer

1315PEfficacy and safety data from patients with advanced non-squamous NSCLC and brain metastases from the nivolumab expanded access programme (EAP) in Italy

1175PComparability of programmed death-ligand 1 (PD-L1) expression on tumor-infiltrating immune cells (IC) and tumor cells (TC) in advanced urothelial bladder cancer (UBC) using clinically relevant immunohistochemistry (IHC) assays

131I-labeled chitosan hydrogels for radioembolization: A preclinical study in small animals.

1252PEarly safety from phase 1b/3, multicenter, open-label, randomized trial of talimogene laherparepvec (T-VEC) + pembrolizumab (pembro) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): MASTERKEY-232

10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD.

1181PPharmacokinetics (PK) and Pharmacodynamics (PD) of cergutuzumab amunaleukin (CA), a carcinoembryonic antigen (CEA)-targeted interleukin 2 variant (IL2v) with abolished binding to CD25

10 Years Later: Lessons Learned from an Academic Multidisciplinary Cosmetic Center.

152PDDouble-blind, randomized phase III study to compare the efficacy and safety of trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early breast cancer (EBC)

1359PImpact on OS and PFS of 2nd and 3rd generation TKI in EGFR mt+ and ALK+ pts: Results of the NOWEL network

1278PDMajor pathological response after preoperative chemotherapy as a surrogate marker of survival in early-stage non-small cell lung cancer: cohort of NATCH phase III trial

10 km CWDM Transmission using 56 Gb/s PAM-4 Directly Modulated Lasers for 200G/400G Transceivers

1-D Fast Neutron Source Localization Using Digital Pixelated 3-D Position-Sensitive CdZnTe Detectors

1049PDRelationship between PD-L1 expression and survival in head and neck squamous cell carcinoma (HNSCC) patients (pts)

1700012B09Rik, a FOXJ1 effector gene active in ciliated tissues of the mouse but not essential for motile ciliogenesis.

[11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice.

1138PDImmune checkpoint inhibitor (ICPI) efficacy and resistance detected by comprehensive genomic profiling (CGP) in non-small cell lung cancer (NSCLC)

12.01: Global plastic design of stainless steel frames

18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease.

153PDOne-year safety, immunogenicity, and survival results from a phase III study comparing SB3 (a proposed trastuzumab biosimilar) and originator trastuzumab in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment

1450PEuropean survey of 907 people with cancer about the importance of nutrition

10-WDM 64-GBaud PDM-64QAM Transmission over all-Raman amplified 840 km SSMF using Digital Back Propagation

1.56GHz/0.9V energy-efficient reconfigurable CAM/SRAM using 6T-CMOS bitcell

150O_PRNot all small node negative (pT1abN0) breast cancers are similar: Outcome results from an EORTC 10041/BIG 3-04 (MINDACT) trial substudy

1018 nm Yb-doped high-power fiber laser pumped by broadband pump sources around 915 nm with output power above 100 W.

1528PDInitial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in combination with nivolumab, in pts with relapsed/refractory (rel/ref) small-cell lung cancer (SCLC)

148OPhase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study

18F-FDG PET/TC en el manejo clínico de los linfomas

1313PImmune-related adverse events (irAEs) in advanced NSCLC patients treated with atezolizumab: Safety population analyses from the Ph III study OAK

16.23: A comparative analysis of longitudinal stiffener cross-section for slender I-girders subjected to patch loading

1395PSpecialized ambulatory palliative care: (SAPV) 5-year results of a multi-professional care model by HomeCare linker Niederrhein gGmbH (HC) in the Lower Rhine region

10.37: Mechanical properties of high strength aluminium alloy at elevated temperatures

12.12: Influence of welding on mechanical properties of high strength steel butt joints

16.15: Experimental evaluation of a novel demountable shear connector for accelerated repair or replacement of precast steel‐concrete composite bridges

1537TiPA phase 3 trial of rovalpituzumab tesirine vs topotecan in patients with advanced small cell lung cancer following frontline platinum-based chemotherapy

10 Gbps Tuneable VCSEL-based SFP+ with Integrated G.METRO Functionality for Front haul Access Networks

1068PThe observational ENCORE study: Cetuximab + platinum-based therapy (PBT) for first-line (1L) treatment of patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

1378TiPA phase 3 study of first-line durvalumab vs platinum-based chemotherapy in patients with advanced NSCLC and high PD-L1 expression: PEARL

1048PDRetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN)

10 Years of Black Girlhood Celebration: A Pedagogy of Doing

11.59: Study on highly elastic seismic structural system based on very‐high strength steel and damage‐control fuses

16.04: High strength steel (HSS) S690 in highway bridges: Comparative design

10.3 bits/s/Hz Spectral Efficiency 54×24 Gbaud PM-128QAM Comb-Based Superchannel Transmission Using Single Pilot

1212TiPPIVOT-02: A phase 1/2, open-label, multicenter, dose escalation and dose expansion study of NKTR-214 and nivolumab in patients with select, locally advanced or metastatic solid tumor malignancies

11C-acetate positron-emission tomography/computed tomography imaging for detection of recurrent disease after radical prostatectomy or radiotherapy in patients with prostate cancer.

152 Complications Associated with Transsphenoidal Pituitary Surgery: Experience of 1171 Consecutive Cases Treated at a Single Tertiary Care Pituitary Center

1035TiPA multicenter, randomized, phase 3 study of pomalidomide and dexamethasone (Pom-dex) with or without daratumumab in patients with relapsed or refractory multiple myeloma (RRMM): APOLLO

11.32: Linked columns with friction dampers as a technique for seismic retrofit of steel moment resisting frames

13.06: Calibration of Eurocode design models of thin-walled cylinder under bending with full scale tests

10.19: The steel and fibre‐reinforced concrete circular hollow section composite column exposed to fire

1185PSafety, pharmacodynamic, and pharmacokinetic profile of TSR-042, an anti–PD–1 monoclonal antibody, in patients (pts) with advanced solid tumors

1153PAn observational clinical study with RAS peptide vaccine TG01 evaluating immune response, safety and overall survival in patients with non-resectable pancreatic cancer

100 μW Coreless Flyback Converter for Microbial Fuel Cells Energy Harvesting

1184PA phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors

1180PDevelopment of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy

162PDPathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification (TNBCtype-4)

10 years follow up of the RASTER study: implementing a genomic signature in daily practice

17.06: Characterization of accidental scenarios for offshore structures

15.10: Probabilistic analysis of steel columns under blast induced loads

10.18: Material properties of high strength steel under fire conditions

12.11: Experimental and numerical studies on Q690D welded Box‐section columns under cyclic loading

1547PDPhase 3 safety evaluation of an intravenous formulation of NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron

1227PAvelumab treatment in chemotherapy-naïve patients with distant metastatic Merkel cell carcinoma (mMCC)

1465P_PRDo oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland

1379TiPPhase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor

14.5Tb/s Mode-Group and Wavelength Multiplexed Direct Detection Transmission over 2.2 km OM2 Fiber

1242PNeutrophil to Lymphocyte Ratio (NLR) as an independent prognostic measure in patients receiving targeted therapy or immunotherapy for stage IV melanoma

1051PDA phase 1, multicenter, open-label, dose-escalation, combination study of RM-1929 and photoimmunotherapy in patients with recurrent head and neck cancer

1147PDGermline determinants of immune related adverse events (irAEs) in melanoma immunotherapy response

16.22: Remarks on the material testing of historical railway bridges: Steelworks built from 1873 to 1950

1574PEfficacy and safety of RGB-02, a proposed biosimilar pegfilgrastim to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind, phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving docetaxel/doxorubicin

112PPathological evaluation of tumor infiltrating lymphocytes and the benefit of nivolumab in advanced non-small cell lung cancer (NSCLC)

1700OGenomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types

1474OImproved overall and progression free survival after surgery in expert sites for sarcoma patients: A nationwide study of FSG-GETO/NETSARC

1039TiPPhase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma

18F-FDG PET/CT in the clinical management of patients with lymphoma

12.16: Numerical investigation of the local buckling behaviour of high strength steel circular hollow sections

1164PPatterns of progression under antiPD1/PDL1 in advanced NSCLC patients allow discriminating pseudo-progression from real progression

156PDTargeted NGS profiling identifies genomic alterations associated with high-risk eBC

11.19: Seismic fragility assessment of steel frames: Application of advanced reliability analysis

1639PTucatinib, a HER2 selective kinase inhibitor, is active in patient derived xenograft (PDX) models of HER2-amplified colorectal, esophageal and gastric cancers

10.33: Flexural buckling behaviour of high strength steel columns under fire conditions

11.06: Application of hybrid simulation for the evaluation of the buckling response of steel braced frame columns

193POncotype DX score, menopausal status and body mass index

103 Racial disparities in pedestrian deaths in the united states, 1999–2015

12.18: Experimental investigation on cold‐formed high strength steel circular hollow sections under combined compression and bending

1269PIntegrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

10 workshops on Immunology of preeclampsia.

11.16: Seismic performance evaluation of MRFS with dissipative continuous columns

12-month prevalence and consequences of current experiences of physical and psychological violence in a sample of patients who entered first time a psychotherapeutic outpatient clinic

1OWild-type KRAS mediates growth inhibition and resistance to MEK inhibitors through dimerization with mutant KRAS in lung adenocarcinoma

10.02: Numerical simulation of fire-resistance test of steel beam

1176PIDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis

1058PDoes hyper-progression exist among head and neck cancer patients treated with immunotherapy?

197PUnderstanding BRCA1 and BRCA2 mutated breast cancer cases in Romania: First report on founder mutations in Romanians

11.24: Impact of column flexural stiffness on behaviour of steel plate shear walls

19.01: A study on the prediction of welding effects in steel box girders

15-Gbaud PAM4 Digital Mobile Fronthaul with Enhanced Differential Pulse Coding Modulation Supporting 122 LTE-A Channels with up to 4096QAM

11.67: Cyclic backbone curves for steel wide‐flange columns: A numerical study

1D-Bernoulli Chaos Sequences Based Collaborative-CDMA: A Novel Secure High Capacity CDMA Scheme

12.03: Buckling curves for stainless steel tubular columns

1506PPD-L1 inhibition – a new therapeutic opportunity in cutaneous angiosarcoma?

18.02: Optimisation of masts and towers

117 Effects of Different Surgical Modalities on Clinical Outcome of Moyamoya Disease: A Prospective Cohort Study

1377TiPJAVELIN Lung 100: updated design of a phase 3 trial of avelumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+ non-small-cell lung cancer (NSCLC)

1055PNivolumab vs investigator’s choice (IC) in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): treatment effect on clinical outcomes by best overall response in checkmate 141

1327PThe Lung Immune Prognostic Index (LIPI), a predictive score for immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) patients

10.31: Simplified analytical determination of the temperature distribution and the load bearing resistance of slim-floor beams

18 beta-glycyrrhetinic acid derivative and application thereof

1209TiPA first-in-human, open-label, multicenter phase 1/2a study to evaluate the safety and efficacy of increased repeated doses of the first in class RORγ agonist LYC-55716 in treating locally advanced or metastatic solid tumors

138PDetection of microsatellite instability (MSI) in colorectal cancer samples with the automated Idylla MSI Test

10.08: Application of advanced materials for enhancing the fire performance of slim‐floors

10.32: Experimental study on high temperature elastic modulus of China made high strength structural steel

10.12: Numerical modelling of steel sheathed LSF walls under fire conditions

1628ODevelopment of the Manchester Cancer Research Centre Molecular Tumour Board for matching patients to clinical trials based on tumour and ctDNA genetic profiling

11.43: Seismic performance of staggered steel plate shear wall systems in high rise buildings

1538TiPA phase 1/2 study on safety of rovalpituzumab tesirine in combination with nivolumab or nivolumab + ipilimumab in small cell lung cancer

1. Targeting Enzymatic Pathways with Marine-Derived Clinical Agents

107PAssociation of tumor and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with response to nivolumab treatment in NSCLC patients

155-mm M795 Aerofuze Test at the KOFA Range, Yuma Proving Ground, Arizona, 19 May 2015

11.23: Influence of the uniaxial material model of steel on the seismic response of steel structures

16th AIAC: “Turbulence, Structures, and Particle Acceleration Throughout the Heliosphere and Beyond”

1682PCompartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer

1354POsimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced NSCLC: Updated Phase II study results including progression-free survival (PFS)

1158PIs objective response rate (ORR) a valid primary endpoint in phase 2 trials (Ph2t) of immune checkpoint inhibitors (ICI) for advanced solid cancers

1186PPhase Ia study of a humanized anti-PD-1 monoclonal antibody (JS001) in Chinese patients with refractory solid tumors

106PThe association between PD-L1 expression, EGFR mutation and ALK translocation in a series of 982 lung cancers

1157PCorrelation and differences in Effect sizes between Progression Free Survival (PFS) and Overall Survival (OS) among PD-1 inhibitors

18F-FDG PET/CT in follow-up evaluation in paediatric patients with Langerhans histiocytosis

12.19: Experimental investigation on residual stresses in welded thick‐walled I‐shaped sections fabricated from Q460GJ structural steel plates

1309PEfficacy and safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)

1497PEfficacy and safety of patients treated long-term with trabectedin (t) on the expanded access program: A retrospective analysis

1208TiPA phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

18F-Choline PET/CT scan in staging and biochemical recurrence in prostate cancer patients: Changes in classification and radiotherapy planning.

1734PDAnti-CTGF human recombinant monoclonal antibody pamrevlumab increases resectability and resection rate when combined with gemcitabine/Nab-paclitaxel in the treatment of locally advanced pancreatic cancer patients

110 °C range athermalization of wavefront coding infrared imaging systems

1245PQuality-of-life (QoL) in COLUMBUS part 1: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in braf-mutant melanoma

107 Preventing fall injuries among elderly in residential care facilities with impact absorbing flooring

1662PSynergistic antitumor effects of OT-101 (trabedersen), a transforming growth factor-beta 2 (TGF-β2) antisense oligonucleotide (ASO) and chemotherapy in preclinical tumor models

13.07: Extension of EN 1993-1-10 and EN 1993-1-12: To higher strengths and thinner sections

1-D Wavelet Signal Analysis of the Actuators Nonlinearities Impact on the Healthy Control Systems Performance

1H and 13C NMR spectral assignments for 24 novel naphthalenylphenylpyrazolines

11.42: Cyclic behaviour of European carbon steels

162A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in the Nursing Home Population

1631PDProminent immune suppressive tumor microenvironment in female never-smoker lung cancer patients with EGFR mutations

18F-FDG PET/CT Scan Can Predate Clinical Presentation in Acute Appendicitis.

132 The Underlying Effect of Burst Stimulation on Chronic Pain Using Multimodal Neuroimaging - EEG, fMRI and PET

16.13: Queensferry crossing cable-stayed composite bridge

1363PEfficacy and safety of abemaciclib combined with either LY3023414 or pembrolizumab in stage IV NSCLC

168PUpdated results of the Breast cancer task force phase II study of neoadjuvant weekly carboplatin (Cp) added to paclitaxel (P) followed by epirubicin (E) and cyclophosphamide (C) in triple negative breast cancer (TNBC) patients (pts)

12.14: Ultimate response and design of stainless steel continuous beams

18.01: Effective Vibration Dampers: Mast, towers and chimneys

143 Pediatric Trigeminal Neuralgia (TN): Results with Early Microvascular Decompression (MVD)

19.04: Diagrid: the renaissance of steel structures for tall buildings geometry, design, behavior

10.17: Mechanical properties of high strength Q690 steel at elevated temperatures

1310PSurvival and safety of atezolizumab by best overall response (BOR) in the phase III NSCLC OAK study

118PNationwide external quality assessment (EQA) of EGFR testing in circulating tumor DNA: The French experience

1502PEvolution in neutrophil-to-lymphocyte ratio (NLR) among advanced soft tissue sarcoma (STS) patients treated with pazopanib within EORTC 62043/62072 trials

1436O_PRHow to assess a cancer therapy? Feedback from the French HTA body on the ESMO-MCBS

1341PAssessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA

1156PItalian nivolumab expanded access programme: real-world results in non-squamous non-small cell lung cancer patients

182PA phase II randomised study of Adjuvant hypo-fractionated radiotherapy with concurrent vs sequential letrozole in post-menopausal women with hormone receptor positive breast cancer: Report of pulmonary toxicity and cosmetic outcome

1467PGenerating patient reported outcome norms for an EU cancer population using real world data (FACT-G)

12.17: Economical design of high strength steel trusses using multi-criteria optimization

11.60: Experimental investigation under cyclic loadings of an innovative passive mitigation device

1723PThe role of hepatocyte nuclear factor 1 homeobox B (HNF1B) loss in chromophobe RCC (ChRCC) development

1472P_PRChange of patient perceptions of chemotherapy side effects in breast and ovarian cancer patients

1142PDSafety, pharmacokinetics (PK) and pharmacodynamics (PD) data from a phase I dose-escalation study of OX40 agonistic monoclonal antibody (mAb) PF-04518600 (PF-8600) in combination with utomilumab, a 4-1BB agonistic mAb

1440PDThe European Cancer Patient Coalition’s white policy paper on the value of innovation in oncology

1169PTopography of Tumor Mutational Burden (TMB) and Immune-related Genomic Alterations (GA) Across Gastrointestinal Malignancies (GIm): A Study of 22,570 Cases

1251PBaseline neutrophil-to-lymphocyte ratio and its values monitored over time is associated with outcome of metastatic melanoma patients treated with immunotherapy

185PThe first report of multicenter validation study of 95-gene classifier, a multi-gene prognostic assay of estrogen receptor positive and node negative breast cancer patients

1×1 Rectangular patch antenna

1-Octanol-water partition coefficient of some cyanopyridine and chalcone compounds

1611TiPA novel multimodal treatment strategy for cancer cachexia; rationale and motivation for the MENAC (Multimodal – Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

1555PPharmacokinetic (PK) study of a single oral dose of NEPA in Chinese healthy volunteers (HVs)

128-Slice MDCT angiographic evaluation of coronary artery anomalies in the South Asian (Indian) population – A first experience

1549PDMulticenter randomized controlled trial to evaluate the efficacy of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy

1270P3D Cultured Tumour from Patients to Predict Treatment Response

113 Testing the Efficacy of Simulation in Neurosurgical Education: First Results of the SENSE Trial

1552PEvaluation of Antiemetic Practices for Prevention of Chemotherapy-induced Nausea and Vomiting (CINV): Results of a European Oncology Nurse Survey

13.05: Imperfection force of members under longitudinal action having a variable sign

11.11: Rocking damage-free steel column base with friction devices: Development of advanced 3D finite element models in Abaqus

1471PAcademic clinical research: Enough players to get out there?

177PEffects of neratinib (N) on health-related quality of life (HRQoL) in early-stage HER2+ breast cancer (BC): longitudinal analyses from the phase III ExteNET trial

17.03: Dynamic properties of unanchored circular ground-based steel tanks

110PPrognostic and predictive value of lymphovascular invasion and lymph node status among breast cancer subtypes

1572PG-CSF and G-CSF biosimilars: a meta-analysis of randomized clinical trials in breast cancer patients

12.02: High strength steel I-section arches: Inelastic lateral buckling and moment capacity

105PBaseline gut microbiota in metastatic melanoma patients treated with ipilimumab: Relation with clinical response and colitis

1183PSafety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of PF 06801591, an anti-PD1 antibody administered intravenously (IV) or subcutaneously (SC)

1 Safety protection system is equipped with a disposable pen needle

1318PItalian nivolumab expanded access programme in non-squamous non-small cell lung cancer patients: Real-world results in never smokers and EGFR positive patients

11.50: Modelling hysteretic behaviour of U-shaped steel dampers

13.13: Earthquake loss assessment of steel moment‐resisting frames designed according to EC8

18 F-FDG PET/CT Imaging of Pulmonary Mucinous Cystadenocarcinoma with Signet Ring Cells

1338PEGFR mutation detection in plasma cell-free DNA correlates with clinical outcomes in non-small cell lung cancer

14PAlterations to trastuzumab-induced antibody-dependent cell-mediated cytotoxicity (T-ADCC) in a lapatinib-resistant HER2+ breast cancer cell line model

121 Violence against older adults: perpetrators and mechanisms of geriatric physical assault injuries treated in us emergency departments, 2006–2014

16.10: Challenges with water ingress in bridge cable systems

1646PClinical factors associated with mutation burden in non-small cell lung cancer

1018PInternational prognostic scores (IPS-7, IPS-3 and IPS-3 new) for prediction of FFS and OS in cases with Hodgkin Lymphoma. Which is more practical and accurate?

192 Craniotomy for Acute Subdural Hematoma-Outcomes in Patients Over 70 years

182 Posterior Micro-Endoscopic Discectomy vs. ACDF for Single-level Radiculopathy: Comparative Effectiveness and Cost-Utility Analysis

104PPharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors

113 Homicides in the city of chicago, 2008–2016

1000MPa-stage non-magnetic stainless steel hot-rolled plate and manufacturing method

13.10: Angles connected by one leg in tension

123I-Meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients showing scans without evidence of dopaminergic deficits (SWEDDs).

11.25: Rocking damage-free steel column base with friction devices: Design procedure and global seismic response of buildings

1,000,000 Giant Pulses from the Crab Pulsar

12V safety adds electrician's dress

13.12: Resistances of I- and U-sections: Combined bending and torsion internal forces

163Overcoming Frailty: Evaluating the Role of an Occupational Therapist on a Frail Elderly Team

16.30: Safety evaluation of a large-span double-deck cable-stayed steel bridge under fire

10.16: Behaviour of high-strength bolts at elevated temperatures under double-shear loading

11.35: Numerical study on steel braces under reversed cyclic loads

120 Rates of Re-hemorrhage, Risk Factors, and Outcomes of Previously Ruptured Arteriovenous Malformations (AVMs)

175POHERA: A real world study of cardiac events in > 3700 patients with her2-positive early breast cancer treated with trastuzumab: Final analysis

1046PDOverexpression of the c-MET proto-oncogene in salivary duct carcinoma patients

1526TiPCDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)

10.22: Comparing the fire behaviour of composite columns made with concrete filled double‐skin and double‐tube steel sections

11.41: Numerical investigation of influence of plate yield point on performance of steel plate shear wall

10.11: Fire design of rectangular hollow section joints

10.38: Effects of heat‐treatment methods on mechanical performance of high‐tensile strength steel subject to elevated temperatures

178PSecond interim analysis of HerSCin, a German non-interventional study of subcutaneous trastuzumab for HER2-positive early breast cancer in routine clinical practice

1972년 이전 체육특기자제도의 궤적: 입시제도 안에 구축된 스카우트 관행

1223PDQuality-adjusted survival of combined nivolumab plus ipilimumab (NIVO+IPI) or NIVO alone vs IPI among treatment-naïve patients (pts) with advanced melanoma (MEL): a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis

13.01: Net cross‐section failure of steel plates at bolt holes: Numerical work and statistical assessment of design rules

109 Impact of a More Restrictive Overlapping Surgery Policy An Analysis of Complication Rates, Resident Involvement, and Surgical Wait Times at a High-Volume Neurosurgical Department

16.11: Experimental tests on the fatigue behaviour of thick-plate trough railway bridges

1355PActivity of afatinib in heavily pretreated patients (pts) with HER2 mutation-positive (HER2m+) advanced non-small cell lung cancer (NSCLC): findings from a global named patient use (NPU) program

1360PPhase II trial of AZD9291 in second line treatment after acquired resistance with T790M mutation detected from circulating tumor DNA (LiquidLung-O-Cohort 2)

10.06: Fire performance of CFS walls with web‐perforated studs–A numerical investigation

192PPopulation sizes of patients (pts) with node negative (N0), HR+, HER2− primary breast cancer (BC), using standard and TAILORx 21-gene recurrence score (RS) cut-off values (COV)

1272PDiagnostic performance of dedicated breast PET scanner with a ring detector

1458PImpact of mastectomy on the social well-being and family dynamics of breast cancer female patients in the Gaza Strip

1637PEph A2 expression is a predictive biomarker of poorer activity and efficacy of FOLFIRI + cetuximab in RAS WT metastatic colorectal cancer (mCRC) patients (pts) in the CAPRI GOIM trial

153Implementing Digital Life Story Work for People with Dementia: The Relevance of Context to User Experience

10.14: Fire design method for eccentrically loaded concrete-filled steel tubular columns based on interaction diagrams

13.08: Plastic resistance of U sections under major‐axis bending, shear force and bi‐moments

1,2,3, many: Perceptual order is computed by patches containing 3x3 repetitions of Motifs

1154PTelomerase peptide vaccine combined with ipilimumab in metastatic melanoma: Reports from a phase I trial

1ª CAMPANHA DO ALTO FORNO 1 DA ARCELORMITTAL TUBARÃO: HISTÓRICO, REFORMA, NOVAS TECNOLOGIAS, PRIMEIROS RESULTADOS DA 2ªCAMPANHA E PERSPECTIVAS FUTURAS

1,25-Dihydroxyvitamin D promotes calcium influx in human skeletal muscle myotubes

12.22: Seismic performance of high capacity hybrid beam-columns: Comprising of high strength steel tubes subjected to lateral cyclic loading

1305PDWhole body PD-1 and PD-L1 PET in pts with NSCLC

11.63: Seismic protection of gas tanks

1047PDMammary analogue secretory carcinoma (MASC): clinical characteristics in 28 ETV6-NTRK3 fusion gene confirmed patients

1092PCASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms in susceptibility and outcome of head and neck squamous cell carcinoma

1091PPrognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC)

1433PBurnout syndrome: What impact on clinical research?

16.07: Flange buckling resistance of trapezoidal web girders: Experimental and numerical study

11.14: Seismic performance of high‐strength‐steel frame with buckling hinge beams in energy dissipation bays

1475PDA randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide and cisplatin (API), followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). Update at 10 years

1609TiPImpact of a cancer care coordination program based on health information technologies for patients treated by oral anticancer therapy: The CAPRI randomized trial

1207TiPAn open-label, Phase IB study of NEO-PV-01 + Adjuvant with Nivolumab in Patients with Melanoma, Non-Small Cell Lung Carcinoma, or Transitional Cell Carcinoma of the Bladder

11.13: Hybrid seismic protection system: Buckling restrained brace of nano‐micro composite magneto rheological damper

1365PEffect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies

13.18: Advanced analysis of braced steel frames: Modelling accounting for the post‐limit behaviour of compressed angle braces

12주간의 규칙적인 중강도 걷기 운동과 자색양파 추출물 섭취가 노인의 신체구성 및 건강체력에 미치는 영향

1525TiPGeriatric assessment of elderly chemotherapy-naïve patients treated with trabectedin for advanced soft tissue sarcomas (STS): The E-TRAB study of the German Interdisciplinary Sarcoma Group (GISG-13)

112-Gbit/sλ PAM4 Transmission enabled by a Negatively-Chirped InP-MZ Modulator

1012PRole of prephase treatment prior to definitive chemotherapy in diffuse large B -cell lymphoma (DLBCL)

1563PLiterature review of TPOR agonists for CIT

12.07: Numerical assessment of stayed austenitic steel columns

124Transient Loss of Consciousness - A Diagnostic Challenge

149 Developing strategies to prevent youth from obtaining illegal firearms

1411PGenetic counseling, screening and risk reducing practices in patients with BRCA mutations

1600POptimizing Physician Surveys in Pharmacovigilance Using ecancer Online Community

11.15: Seismic behaviour of single layer cylindrical lattice steel shells

194 Endoscopic Assisted Evacuation of Chronic Subdural Hematoma A Paradigm Shift or a Waste of Time

1531PDClinical outcomes for EGFR-mutant adenocarcinomas (AC) that transform to small cell lung cancer (SCLC)

100Potentially Inappropriate Prescribing of Proton Pump Inhibitors – A Qualitative Study

161 Greening vacant properties: an innovative approach to youth violence prevention

16.29: Determination of the residual stress distribution of steel bridge components by modelling the welding process

1325PGeneralization and representativeness of phase III immune checkpoint inhibitor trials in NSCLC

11.40: Cyclic bending of multi-stiffened plate girders: Numerical model development and analysis

10.34: Creep properties of grade S275JR steel at high temperature

15.15: Dynamic Analysis of Steel-Concrete Composite Building Floors Subjected to Human Rhythmic Activities

143PA comparison of treatment recommendations by molecular tumor boards worldwide

134Palliative Care in Nursing Home Residents: Are we Doing Enough?

1536TiPAn open-label study on safety and tolerability of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

1438O_PRReport on ESMO/SIOPE European Landscape project key results: Mapping the status and needs in AYA cancer care

11.57: Assessment of the ductile behaviour of CBF structures considering energy dissipation in bolted joints

1625PPhase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma

1032PPharmacodynamic and pharmacokinetic evaluation of SY-1425 (tamibarotene) in biomarker-selected acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients

16.08: The dynamic behaviour of the third Bosporus Bridge

11.36: Influence of type of loading protocols and restraining parameters on cyclic response of steel BRB

1515PLncRNA H19, HOTAIR and MALAT1 as prognostic molecular biomarkers in GIST

11.56: Test rig for seismic experiments of drive-in racks

10.20: Numerical simulation of the behaviour of steel members with damaged SFRM fire protection coatings at elevated temperatures

11.55: Development of a 2-dof model simulating the dynamic response of special truss moment frames with shape memory alloy bars as dissipation devices in the special segment

127 Attention, distraction, and crashes: working memory and texting while driving predict crashes in young novice drivers

1386OCancer cachexia (CAX), anorexia and muscle wasting (sarcopenia) assessment in non-small cell lung cancer (NSCLC): an observational study in 531 patients

122PCell-free (cf)DNA analysis identifies PIK3CA/AKT1 mutations associated with greater PFS improvement from the addition of ipatasertib (IPAT) to paclitaxel (P) in triple-negative breast cancer (TNBC)

10.09: Critical temperatures of members with class 4 cross-section

19.02: Exploring the potentials of metal foams in structural elements for civil/building applications

15.04: Parametric study on steel beams with fin‐plate joints under falling floor impact

1691PAnalysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX

1056PEstimated costs of treatment-related adverse events (TRAEs) for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the checkmate 141 trial

113Analysing the Burden of Care of Informal Carers of People with Moderate or Severe Dementia

103PComparison of continuous measures across diagnostic PD-L1 assays using image analysis

170PImpact of neoadjuvant therapy (NT) and pathological complete response (pCR) on breast-conserving surgery (BCS) in patients (pts) with breast cancer (BC): A meta-analysis

1107TiPPhase II trial of abiraterone acetate in patients with relapsed and/or metastatic, castration resistant AR expressing salivary glands carcinomas (SGCs)

1702OClinical implications of genomic variants identified in over 30,000 advanced-stage cancer patients by next-generation sequencing of circulating tumor DNA

1231PRole of an intronic polymorphism in the CREB1 gene, involved in melanogenesis, with the risk and the aggressiveness of cutaneous melanoma

12.05: Global buckling behaviour of welded Q460GJ steel box columns: Experimental study and numerical simulations

19.05: CLT‐steel composite slimfloor construction: An investigation of mechanical behaviour using finite element software

1239PValidating prognostic models in metastatic uveal melanoma (MUM), an international rare cancers initiative

1496PEORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapy

12.10: Structural response of high strength steel hollow sections under combined biaxial bending and compression

17.05: Advanced framework for suction bucket jacket design

141PIschemic stroke and cancer correlation: A stroke unit experience

1060PProgrammed death ligand-1overexpression is a poor prognostic factor for Human papillomavirus-positive tonsillar squamous cell carcinoma

16.16: Medium span steel‐concrete composite bridges: plate girders or box girders

1996-2016 – A CPLP, Uma organização para quê?

1418PClinical features and outcomes of reversible posterior encephalopathy syndrome following bevacizumab treatment

13.15: Seismic design of steel moment resisting frames: Modal strength reduction factors including strength deterioration and panel zone effects

1498PEfficacy and safety of trabectedin in an elderly patient subgroup (≥65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the Expanded Access Program (EAP)

1100PThe phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for head and neck cancer patients

10.26: Parametric numerical analysis of cold-formed steel Σ-shaped beams under fire

1308PDPreliminary efficacy and safety of lorlatinib in patients (Pts) with ROS1-positive non-small cell lung cancer (NSCLC)

1124P_PRImpact of licensing and reimbursement discrepancies on patient access to cancer treatments across Europe and Canada

1041TiPMP0250 – a dual inhibitor of VEGF and HGF - plus bortezomib + dexamethasone in a phase 2 open-label, single-arm, multicenter trial in patients with refractory and relapsed multiple myeloma (RRMM)

15.13: Discrete sizing optimization of trussed steel portal frames according to Eurocode 3

11 Do firearm regulations work? evidence from the australian national firearms agreement

1697PAssessing functional Androgen Receptor (AR) pathway activity using a computational model

1362PSafety and clinical activity of DS-6051b, a ROS1/NTRK inhibitor, in Japanese patients with NSCLC harboring ROS1 fusion gene

136PEpigenetic biomarkers in breast cancer: Preliminary results from H3K27m3 assessment in endocrine-treatment resistance

1130PInvestigating discrepancies in assessments of PFS by study investigators and independent review

108PCharacterisation of heterogeneity in microsatellite instable (MSI) tumours associated with distinct cell types and immune phenotypes

10.04: Behaviour of plane frames of high strength steel in fire

16.12: Winning steel solution for flat arch bridge

123PGenotyping circulating tumor DNA identifies metastatic colorectal cancer (mCRC) patients highly sensitive to Sym004

1428PFamily-associated factors influence the postoperative prognosis in patients with non-small cell lung cancer

1339PA large prospective cohort study of the clinical features of advanced lung cancer harboring HER2 aberrations (HER2-CS STUDY)

1382TiPInvestigation of biomarkers in patients with adenocarcinoma of the lung receiving nintedanib according to approved label: Non-interventional LUME-BioNIS study

1V Differential Input Stage with Bulk-Driven Current Mirror for Low-Voltage Operational Amplifier

1376TiPPhase III study of atezolizumab (atezo) vs chemotherapy (chemo) in patients (pts) with treatment-naive advanced, recurrent or metastatic NSCLC unsuitable for platinum (plat)-based chemo

1351PThe addition of apatinib to gefitinib or icotinib for advanced non-small cell lung cancer with acquired resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitor: An assessment of effectiveness and safety

1616OMulticenter, nonrandomized, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy: results in malignant pleural mesothelioma (MPM)

126 Law enforcement agencies’ and gun retailers’ roles in gun storage for suicide prevention

1445PInclusion of older patients with colorectal cancer in clinical trials: the SAGE prospective multicenter cohort study

1658PSomatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance

11.44: An integrated experimental and numerical assessment of force‐based design for concentrically braced steel frames

1D inverse problems of electromagnetic theory of layered inhomogeneous anisotropic media

1161PA standardized comparison of outcomes in patients (pts) with refractory, aggressive non-hodgkin Lymphoma (rNHL) from the SCHOLAR-1 analysis and the ZUMA-1 study of axicabtagene ciloleucel (axi-cel)

105 Rates of violence and substance use among a high-risk sample during the flint water crisis (fwc): results from the flint youth injury study

133The Great Escape: Virtual Reality as a Complementary Therapy in the Elderly in Residential Settings, a Pilot Study

1350PPhase I study of TAS-121, a novel third-generation epidermal growth factor receptor (EGFR) inhibitor, in patients with EGFR mutation-positive non-small-cell lung cancer (NSCLC)

1061PThe prognostic role of PD-L1 expression in tumor and immune cells in oral cavity squamous cell carcinoma

1540OFosaprepitant reduces the impact of nausea on daily function during five weeks of chemo-radiotherapy: A sub-study of the GAND-emesis trial

1326PLong-term follow-up results of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with an epitope derived from Indoleamine 2,3 Dioxygenase (IDO) in a phase I study

1204PConcurrent immuno-radiotherapy in lung and renal cancer- a new treatment paradigm

14 Development and initial validation of a distracted driving survey for teen drivers

1607TiPJ-FORCE study: A randomized, double-blind, placebo-controlled phase III study evaluating olanzapine (5 mg) combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based, highly emetogenic chemotherapy

1676PComparison of progression-free survival (PFS) on comprehensive multiplatform profiling-guided therapy to PFS on prior therapy: A pooled analysis from 4 contemporary prospective studies

19.07: The steel roof of the new Lille Stadium: Its mechanical scheme, its assembly and erection sequences

1545PDThe effect of cannabis use on tumor response to nivolumab in patients with advanced malignancies

10.13: Bending resistance evaluation of shallow floor beams exposed to fire

1548PDQuality of life (QOL) evaluation of patients in a phase 3 study comparing NEPA with an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV)

1189P4SC-202 plus anti-PD1: Breaking PD1-refractoriness to increase efficacy of checkpoint inhibition in patients with advanced melanoma

1316PEfficacy and immune activation with PEGylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC: Update

1038TiPPhase 2 randomized study of daratumumab (dara), lenalidomide (R), bortezomib (V), and dexamethasone (d; Dara-RVd) vs. RVd in patients (pts) with newly diagnosed multiple myeloma (MM) eligible for high-dose therapy (HDT) and autologous stem cell transplantation (ASCT)

1093PResource-stratification of national comprehensive cancer network (NCCN®) head and neck cancers guideline

1129PReal world treatment costs and resource utilization among patients with metastatic bladder cancer

14. Restrictive Covenants and Protection of Trade Secrets and Confidential Information

1481PDEfficacy and safety of palbociclib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib

146 The role of campus climate and sense of belonging on the use of behavioural health services by college students: a longitudinal examination of the healthy minds study

197 first MTP-joint fusions – A specific analysis regarding consolidation and risk factors

1452PRisk of malignant mesothelioma in Spain from environmental asbestos exposure

129PFirst prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis

110 Neurosurgery Morning Huddle Reduces Costs and Increases Patient Satisfaction

16.03: Structural analysis of the historical Széchenyi: chain bridge in Budapest

188PThe impact of Oncotype DX breast cancer assay results on clinical practice: A UK experience

1022PSafety and tolerability of chemotherapy (CT) containing high doses of methotrexate (HD-MTX) and cytarabine (Ara-C) in patients with primary central nervous system lymphoma (PCNSL) and hepatitis B virus (HBV) infection

1230PModulation of Risk and Prognosis of Cutaneous Melanoma Patients by Genetic Polymorphisms on PDCD1 Gene

14 GHz longitudinally detected electron spin resonance using microHall sensors

1505PAnalysis of expression of immunomodulation factors in alveolar soft-part sarcoma: a retrospective study from the Spanish Group for Research on Sarcoma (GEIS)

133PHeparinase enables reliable quantification of circulating tumor DNA from heparin plasma samples by droplet digital PCR

1501PSafety and efficacy of pazopanib (PAZ) in advanced soft tissue carcinoma (aSTS) by prior lines of therapy, age, and dose modifications: PALETTE subgroup analyses

1641PCombination of duligotuzumab, anti HER3 antibody or taselisib, Pi3k inhibitor with trastuzumab shows synergistic antitumoral activity in HER2 positive gastric cancer cells (GCC)

127 A Novel Scoring System for Preoperative Prediction for Pain-Free Survival After Microsurgery for Trigeminal Neuralgia: TN-MVD Score

1/2-Approximation polynomial-time algorithm for a problem of searching a subset

176PClinical outcomes of delayed start of trastuzumab treatment in patients with early breast cancer: ml25232 study

1356POctogenarians with EGFR-mutated non-small cell lung Cancer (NSCLC) treated by Tyrosine Kinase Inhibitor (TKI): A multicentric real world study assessing tolerance and efficacy. OCTOMUT study GFPC 07-15

15 Temmuz Şehitler Köprüsü gişe sahasının trafik akımına etkisinin araştırılması

11.64: Seismic behaviour of steel Chevron bracing systems by non-linear dynamic analyses

1034TiPPhase III randomized, double-blind, controlled studies of the PI3K inhibitor copanlisib in combination with rituximab or rituximab-based chemotherapy in subjects with relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL): CHRONOS-3 and CHRONOS-4

1694PExpression of estrogen receptors and beta-III tubulin in non-small cell lung cancer tissue

166 TLR-4-Regulated Cerebrospinal Fluid Hypersecretion in Post-Hemorrhagic Hydrocephalus

1145PDAdoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic ovarian cancer: A pilot study

1 × 1 der Dermatohistologie. Teil 2 – Tumoren der Haut

12.04: Experimental and numerical investigation on the Q690 high strength steel slender columns of welded H‐sections under compression

10.28: Fire performance of concrete filled steel tubular columns with built‐in stirrups

11.46: The design of suspended zipper braced frames in the framework of eurocode 8

16.14: Operational, ecological and economical assessment of steel railway bridges

15.17: Progress in the development of production of heavy plates. S355-S460ML till 100 mm at NLMK DanSteel

171Range of Diagnoses Received by Patients Aged 50 and under Attending a Memory Clinic for First Assessment

18 GHz propagation measurements and analysis in Belo Horizonte/Brazil

15.16: Vibration Analysis and Human Comfort Investigation of a Steel‐Concrete Composite Building under Nondeterministic Wind Loadings

15.07: Second‐order direct analysis of long‐span roof structures

12.13: On recent characterisations of the post-yield properties of structural carbon steels

1st European Congress of Medical Physics September 1-4, 2016; Medical Physics innovation and vision within Europe and beyond.

11.12: Derivation of the cyclic behaviour of components in bolted end-plate beam-to-column joints using FEM

16.17: N-M-Q interaction of cross sections in steel-concrete double composite girder bridges

159Age and their Related Comorbidities may lead to Prolonged Hospital Stay in the Elderly

11.49: Lifetime seismic performance assessment of steel frame structures

147Rapidly-progressive Cerebral Amyloid Angiopathy: A Bleeding Catastrophe

11.65: An axial type self‐centering energy dissipation device with shape memory alloy for seismic mitigation

16.28: High speed railway bridge - Copenhagen and Ringsted - TP 30: The longest composite railway girder bridge in Denmark

10.25: Numerical fire tests on the columns of the Cardington steel-framed building

174Prevalence of Bowel Colonisation with Clinically Significant Bacteria among Highly Dependent Residents in a Private Long Term Care Facility (LTCF)

18 F-FDG PET/CT in initial staging and treatment response evaluation in a patient with thymoma.

1,3-hexethyl propylene hydroxide and preparation method and application

165Association of Drug Burden Index with Physical Function in Irish Older Adults with Intellectual Disability

146Obstructive Sleep Apnoea: Should we Screen for This in Stroke?

13.14: Seismic assessment and strengthening of existing steel moment‐resisting frame buildings: the European EC8‐3 and current challenges

12.15: Structural performance of stainless lap bolted joints

16.31: Use of API specified steel tubes for infrastructure applications in Europe

11.09: Validation of probabilistic theory of plastic mechanism control by means of Monte Carlo simulations

150 Jahre „Kapital“ – und kein Ende: Unsystematische Anmerkungen zu einer unendlichen Geschichte

16.27: Fabrication activities and quality aspects of the Third Bosphorus Bridge orthotropic steel deck

1,2,4-Triazole-3-thiol-protected silver-nanoparticles as a platform for ECE electrochemical reaction

11.53: Reduced cross-sections in seismic resistant steel structures

11.48: An experimental study on welded overlap core: Steel encased buckling‐restrained braces

11.62: A numerical study on the seismic performance of experimentally-tested steel single-storey concentrically braced frames

15.05: The experiment of H-shaped beams with continuous restraint on upper flange

145A Review of Cerebrospinal Fluid Samples Sent for Xanthochromia - A Necessary Test in the Diagnosis of Subarachnoid Haemorrhage?

11.51: Numerical investigation of short seismic links in shear

11.30: Experimental behaviour of base plate joints equipped with self‐centering system and friction dampers

12.20: Mechanical properties of cold‐formed stainless steel

187Participants’ Perspectives and Preferences on Clinical Trial Result Dissemination: The TRUST Thyroid Trial Experience

12.23: Research on low-yield-point steels in Tsinghua University

15.08: Influence of deterioration modelling on local deformation demands in steel moment frames

10.35: Influence of joint stiffness on the behaviour of steel bearing frame under fire conditions

182An Audit of Appropriate Proton Pump Inhibitor Prescribing in an Older Inpatient Cohort

11 Caring for patients in a faith based setting: demonstrating a model for ‘hard to reach’ communities and achieving preferred place of death

10.27: Contribution from the flanges to the shear buckling resistance of steel plate girders at normal and elevated temperatures

13 What works, for whom and in which circumstances when implementing the namaste advanced dementia care programme in the home setting?

11.21: Experimental evaluation and explicit fracture simulations of stainless steel seismic dampers

11.08: Reliable calibration of cyclic models for steel members

18.06: Preliminary transition piece design for an onshore wind turbine

11.28: Seismic response of built‐up steel columns with semi‐continuous base‐plate connections: Experimental results vs. theoretical predictions

16 The significance of intimate relationships at end of life: experiences of young adults with life-limiting or life-threatening conditions

11.04: Examination of the Canadian provisions for the seismic stability of steel structures

18.04: Experimental investigations of members from angle sections

15.11: Lab testing and modelling of thermal break assemblies: Mitigating structural penetrations in building envelopes

10.23: Parametric study on the fire resistance of steel columns with thermal gradients

11.18: Seismic analysis of innovative hybrid steel concrete coupled walls

15.02: Direct analysis of steel frames with non-prismatic sections via tapered beam-column elements

11.52: Local buckling behavior and plastic deformation capacity of H-shaped beams under reversed axial forces

11.34: Cross-aisle seismic behaviour of drive-in rack systems

16.18: DYNA® link anchor box: Innovative structure for anchoring stay cables

11.37: Hybrid tests of a full‐scale two‐story buckling‐restrained braced RC frame

10.29: The thermal response of corrugated web beams subjected to fire

16×25 GHz Optical OFDM Demultiplexer in a 220nm Silicon Photonics Platform using a Parallel-Serial Filter Approach

10.30: Mechanical response of steel structures in fire: Influence of different material and creep models

14.05: A mehcanical model of composite floor systems under internal column-removal scenarios

173The Alzheimer’s Questionnaire: Optimising Cut Points for an Irish Memory Clinic Population

15.12: On imperfection-sensitivity evaluation of BMRF systems: Buckling and post-buckling responses

11.27: Elastic buckling load and load resistance of core-separated assembled BRB confined by two concrete-infilled tubes

18.05: Second-order effects of cantilever concrete filled double skin tube (CFDST) transmission towers

11.10: Probabilistic theory of plastic mechanism control

12.08: Cross‐section stability of stainless steel channel sections subjected to combined loading

100 Successful Years of Vertical Lift Gates of Bhatghar Dam—Design, Manufacturing, Erection, and Maintenance: A Case Study

16S rRNA Metagenomics of Asian Gut Microbiota

11.17: Seismic retrofitting of concentrically braced frames by rocking walls and viscous dampers

10.03: Numerical investigation on the fire behaviour of steel beams with local fire protection damages

16.09: Influence of arch bridge skewness

10.21: Post-fire response of slender concrete-filled steel tubular columns

1. Wissenschaftspreis - Assoziation zwischen der Mammografischen Dichte und Schwangerschaften in Abhängigkeit von Alter und BMI – eine Fallstudie zu Brustkrebs

11.45: Cyclic testing on hybrid buckling‐restrained Braces (HBRBs)

11.54: A proposal to improve the seismic behaviour of eccentrically braced structures

10.36: Advanced numerical analysis of steel, concrete and composite structures under fire conditions

181Improving Documentation of DNACPR and Treatment Escalation Plans in a Dublin Teaching Hospital

1,3- and 1,4-Benzdiyne Equivalents

11.38: Investigation of innovative steel concentrically braced frame connections using advanced analytical models

Discover 601 research papers published on 1st September, 2017 starting with "1"

Discover 601 research papers published on
1st September, 2017 starting with "1"